Biotech · Private company · Research Triangle Park, NC, US
Dignify Therapeutics
Track this companyFree. Adds Dignify Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- DTI-117Phase 1 · Healthy AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.PHASE1 · RECRUITING · started Oct 28, 2026ClinicalTrials.gov NCT07882472 · fetched Nov 12, 2026
NIH awards7
- Preclinical and Early Clinical Development of a Novel Drug for On-Demand VoidingFiscal year 2026 · $94.8KNIH RePORTER 3U44NS129628-04S1 · fetched Nov 12, 2026
- Preclinical and Early Clinical Development of a Novel Drug for On-Demand VoidingFiscal year 2026 · $199.5KNIH RePORTER 5U44NS129628-04 · fetched Nov 12, 2026
- Novel treatment for urinary incontinence and overactive bladder symptoms in the elderlyFiscal year 2025 · $110KNIH RePORTER 5R43AG088838-02 · fetched Nov 12, 2026
- Preclinical and Early Clinical Development of a Novel Drug for On-Demand VoidingFiscal year 2025 · $976.9KNIH RePORTER 5U44NS129628-03 · fetched Nov 12, 2026
- Novel treatment for urinary incontinence and overactive bladder symptoms in the elderlyFiscal year 2024 · $389.9KNIH RePORTER 1R43AG088838-01 · fetched Nov 12, 2026
- Therapy for Fecal Incontinence and FecalUrgencyFiscal year 2024 · $391.5KNIH RePORTER 1R43DK138600-01A1 · fetched Nov 12, 2026
- Preclinical and Early Clinical Development of a Novel Drug for On-Demand VoidingFiscal year 2024 · $1.5MNIH RePORTER 4U44NS129628-02 · fetched Nov 12, 2026